Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TIRATROP
NCT02505399Phase 4Completed
- Sponsor
- Centre hospitalier universitaire de Toulouse
- Start
- Nov 2015
- Primary completion
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of ticagrelor in atherosclerosis (2 arms), sponsored by Centre hospitalier universitaire de Toulouse. Primary endpoint: Area under the curve corresponding to troponin level as a function of time at 24 hours. Started Nov 2015; status: completed.
02
Drugs
ticagrelor
03
Conditions
atherosclerosis
Beyond the preview
Go deeper on NCT02505399.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02505399.